Cansino Biologics Inc Cansinobiois A Prominent Chinese Biopharmaceutical Company Focused On The Researchdevelopmentmanufacturingand Commercialization Of Innovative Vaccines For Infectious Diseasesfounded In 2009 In Tianjinchinathe Company Has Established Itself As A Key Player In The Global Vaccine Industrydedicated To Enhancing Public Health Worldwide Headquartered In Tianjincansinobio Operates Manufacturing Facilities In Chinamexicopakistanand Malaysiathe Company Is Publicly Traded And Has Successfully Raised Capital To Support Its Growth And Research Effortscansinobio S Vaccine Portfolio Includes Notable Products Such As Convideciaa Single Dose Covid 19 Vaccineand Convideciaairan Inhaled Version Of The Vaccineother Vaccines In Their Lineup Target Meningitis And Ebolaamong Other Infectious Diseasesthe Company Employs Advanced Technologiesincluding Adenovirus Vector And Mrna Platformsto Develop Its Vaccines Efficiently Cansinobio Aims To Provide Global Solutions For Preventing And Treating Infectious Diseasesworking Closely With Public Health Sectorsgovernmentsand Healthcare Providers To Support Immunization Efforts Around The World
